Blood marker may reduce cancer burden
Researchers at Flinders University are expanding work on a promising blood test model to help…
Browsing: Head and Neck Cancers
Strong, durable responses to selpercatinib in RET-driven medullary thyroid cancer
Selpercatinib (Retevmo), a drug targeted precisely against cancers driven by mutations or alterations in the…
Robotic surgery may improve outcomes in mouth and throat cancer
Robotic surgery for patients with early stage, oropharyngeal squamous cell cancer is associated with improved…
Queensland Brain Cancer Clinical Trial Gives Hope to Patients
Queensland researchers have found that patients who received a cellular immunotherapy for the deadly brain…
Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma
A nanomedicine-based strategy for chemo-immunotherapy (CIT) of glioblastoma (GBM), which has the worst prognosis among…
Study suggests new approach to improve radiation therapy resistance in glioblastoma
Many modern cancer drugs target a specific genetic mutation that is driving a particular cancer’s…
Precision medicine identifies key recurring mutation in head and neck cancers
Head and neck cancer is one of the leading causes of cancer-related deaths worldwide, and…
Precision medicine identifies key recurring mutation in head and neck cancers
Head and neck cancer is one of the leading causes of cancer-related deaths worldwide, and…
New drug targets for lethal brain cancer discovered
More than 200 genes with novel and known roles in glioblastoma – the most aggressive…
New keys found for unlocking head and neck cancer treatments
QIMR Berghofer scientists say the discovery of new cellular immunotherapy targets for a deadly type…